Universidade Federal de Mato Grosso do Sul, Instituto de Química, Laboratório LP4, Av. Filinto Müller, 1555, 79070-900 Campo Grande (MS), Brazil.
Bioorg Med Chem Lett. 2013 Aug 15;23(16):4669-73. doi: 10.1016/j.bmcl.2013.06.009. Epub 2013 Jun 12.
We have devised a procedure for the synthesis of analogs of combretastatin A-4 (CA-4) containing sulfur and selenium atoms as spacer groups between the aromatic rings. CA-4 is well known for its potent activity as an inhibitor of tubulin polymerization, and its prodrugs combretastatin A-4 phosphate (CA-4P) and combretastatin A-1 phosphate (CA-1P) are being investigated as antitumor agents that cause tumor vascular collapse in addition to their activity as cytotoxic compounds. Here we report the preparation of two sulfur analogs and one selenium analog of CA-4. All synthesized compounds, as well as several synthetic intermediates, were evaluated for inhibition of tubulin polymerization and for cytotoxic activity in human cancer cells. Compounds 3 and 4 were active at nM concentration against MCF-7 breast cancer cells. As inhibitors of tubulin polymerization, both 3 and 4 were more active than CA-4 itself. In addition, 4 was the most active of these agents against 786, HT-29 and PC-3 cancer cells. Molecular modeling binding studies are also reported for compounds 1, 3, 4 and CA-4 to tubulin within the colchicine site.
我们设计了一种合成类似物的方法,这些类似物含有硫原子和硒原子作为芳环之间的间隔基团。CA-4 是一种众所周知的微管蛋白聚合抑制剂,其前药 CA-4 磷酸盐(CA-4P)和 CA-1 磷酸盐(CA-1P)除了具有细胞毒性化合物的活性外,还被作为抗肿瘤剂进行研究,可导致肿瘤血管塌陷。在这里,我们报告了 CA-4 的两个硫类似物和一个硒类似物的制备。所有合成的化合物以及几种合成中间体都被评估了对微管蛋白聚合的抑制作用以及对人癌细胞的细胞毒性活性。化合物 3 和 4 在纳摩尔浓度下对 MCF-7 乳腺癌细胞具有活性。作为微管蛋白聚合抑制剂,3 和 4 都比 CA-4 本身更具活性。此外,4 对 786、HT-29 和 PC-3 癌细胞的活性最高。还报告了化合物 1、3、4 和 CA-4 在秋水仙碱结合位点与微管蛋白结合的分子建模结合研究。